Marta Cobo Marcos, Rafael de la Espriella, Jara Gayán Ordás, Pau Llàcer, Antonia Pomares, Aleix Fort, Inés Ponz de Antonio, Ana Méndez, Zorba Blázquez-Bermejo, Pedro Caravaca Pérez, Jorge Rubio Gracia, Alejandro Recio-Mayoral, Isabel Zegrí, José Manuel García Pinilla, Esther Montero Hernández, Almudena Castro, María José Soler, José Luis Górriz, Ramón Bascompte Claret, Paula Fluvià-Brugués, Luis Manzano, Julio Núñez
INTRODUCTION AND OBJECTIVES: Patients with combined heart failure (HF) and chronic kidney disease (CKD) have been underrepresented in clinical trials. The prevalence of CKD in these patients and their clinical profile require constant evaluation. This study aimed to analyze the prevalence of CKD, its clinical profile, and patterns of use of evidence-based medical therapies in HF across CKD stages in a contemporary cohort of ambulatory patients with HF. METHODS: From October 2021 to February 2022, the CARDIOREN registry included 1107 ambulatory HF patients from 13 HF clinics in Spain...
May 20, 2023: Revista Española de Cardiología